Farragher, T. M., Lunt, M., Plant, D., Bunn, D. K., Barton, A., & Symmons, D. P. M. (2010). Benefit of early treatment in inflammatory polyarthritis patients with anti–cyclic citrullinated peptide antibodies versus those without antibodies. John Wiley & Sons, Inc.

Farragher, Tracey M., Mark Lunt, Darren Plant, Diane K. Bunn, Anne Barton, ja Deborah P M. Symmons. Benefit of Early Treatment in Inflammatory Polyarthritis Patients With Anti–cyclic Citrullinated Peptide Antibodies Versus Those Without Antibodies. John Wiley & Sons, Inc, 2010.

Farragher, Tracey M., et al. Benefit of Early Treatment in Inflammatory Polyarthritis Patients With Anti–cyclic Citrullinated Peptide Antibodies Versus Those Without Antibodies. John Wiley & Sons, Inc, 2010.